Mediverify Database
.png)
.png)
Welcome to the official website of the National Medicine Regulatory Authority of Sri Lanka. We are dedicated to ensuring the safety and efficacy of medicines for the people of Sri Lanka.
The National Medicine Regulatory Authority of Sri Lanka is committed to ensuring the safety, efficacy, and quality of medicines in the country. We strive to protect public health by regulating the manufacturing, importation, distribution, and sale of medicines.
NMRA regulates medicines, medical devices, borderline products imported to and manufactured in Sri Lanka. We also regulate pharmacies. Clinical trials conducted in Sri Lanka are also regulated by us.
Find Out MoreNational Medicines Quality Assuarance of the NMRA is responsible for the analyzing of the quality of any medicine, medical device or borderline product forwarded by the Authority. It functions as an additional approved analyst when the circumstance so requires.
Find Out MorePharmacovigilance Division is responsible for monitoring and dealing with adverse drug reaction, quality failure and counterfeit medicines.
Find Out MoreInspectorate and Enforcement Division is responsible for inspecting and investigating issues pertaining to proper implementation of the provision of the NMRA Act.
Find Out MoreNational Medicines Regulatory Authority,
State Engineering Corporation Building (2nd Floor),
No. 130,
W.A.D Ramanayaka Mawatha,
Colombo 02,
Sri Lanka
Important Notice: Updated Import/Consignment Data Submission Format
The National Medicines Regulatory Authority(NMRA) has introduced a new standardized format for submitting import / manufacturing consignment data. This updated format is now applicable to the following product categories:
· Medicines
· Medical Devices
· Borderline Products
· Cosmetics
All importers and local manufacturers required to use the new format for submitting their import/ manufacturing data.
What’s New?
· Updated table structure
· More detailed product information fields
· Applicable to a wider range of regulated products
Effective Immediately:
· The new format must be used for submissions covering the January–March, April-June, July–September and October-December quarters.
· Submissions using the old format will no longer be accepted.
Access the New Format:
Click here to download the new data submission format:
For any queries or clarifications, please contact: mcimport@nmra.gov.lk
(Previously submitted import/ manufacturing data in the old format can be accepted, but new submissions must follow the new format.)
01. Notice on Products which contained Overages
The National Medicines Regulatory Authority, Sri Lanka has decided to implement certain requirements for the products which contained overages of Active Ingredients.
The requirements are as follows:
02. Notice on Labeling Requirement for Vitamin K containing products
The National Medicines Regulatory Authority has decided to implement certain changes to the labeling requirements of Borderline Products that contained vitamin K to enhance safety measures for the general public.
The requirements are as follows:
NMRA has extended the grace period for the implementation of product-specific QR codes or barcodes on all commercial packing from 31st May 2025 to 31 December 2025.
To All Marketing Authorization Holders of Medical Devices, are hereby informed that Medical Device Dossiers will be accepted on 11th of June 2025 instead of 10th of June 2025 due to the public holiday (Poya Day). Sorry for the inconveniences caused
